ID   FA10_RAT                Reviewed;         482 AA.
AC   Q63207;
DT   07-JUN-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   24-JUL-2024, entry version 178.
DE   RecName: Full=Coagulation factor X;
DE            EC=3.4.21.6;
DE   AltName: Full=Stuart factor;
DE   Contains:
DE     RecName: Full=Factor X light chain;
DE   Contains:
DE     RecName: Full=Factor X heavy chain;
DE   Contains:
DE     RecName: Full=Activated factor Xa heavy chain;
DE   Flags: Precursor;
GN   Name=F10;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley;
RX   PubMed=8578539; DOI=10.1016/0049-3848(95)00151-g;
RA   Stanton C., Ross R.P., Hutson S., Wallin R.;
RT   "Evidence for competition between vitamin K-dependent clotting factors for
RT   intracellular processing by the vitamin K-dependent gamma-carboxylase.";
RL   Thromb. Res. 80:63-73(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thymus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3] {ECO:0000305}
RP   INTERACTION WITH TICK IXOLARIS.
RX   PubMed=16807644; DOI=10.1160/th06-02-0105;
RA   Nazareth R.A., Tomaz L.S., Ortiz-Costa S., Atella G.C., Ribeiro J.M.,
RA   Francischetti I.M., Monteiro R.Q.;
RT   "Antithrombotic properties of Ixolaris, a potent inhibitor of the extrinsic
RT   pathway of the coagulation cascade.";
RL   Thromb. Haemost. 96:7-13(2006).
CC   -!- FUNCTION: Factor Xa is a vitamin K-dependent glycoprotein that converts
CC       prothrombin to thrombin in the presence of factor Va, calcium and
CC       phospholipid during blood clotting. Factor Xa activates pro-
CC       inflammatory signaling pathways in a protease-activated receptor (PAR)-
CC       dependent manner (By similarity). {ECO:0000250|UniProtKB:P00742}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Selective cleavage of Arg-|-Thr and then Arg-|-Ile bonds in
CC         prothrombin to form thrombin.; EC=3.4.21.6;
CC   -!- ACTIVITY REGULATION: Inhibited by SERPINA5. {ECO:0000250}.
CC   -!- SUBUNIT: The two chains are formed from a single-chain precursor by the
CC       excision of two Arg residues and are held together by 1 or more
CC       disulfide bonds. Forms a heterodimer with SERPINA5 (By similarity).
CC       Interacts with ixolaris, an anticoagulant protein from Ixodes
CC       scapularis saliva (PubMed:16807644). {ECO:0000250,
CC       ECO:0000269|PubMed:16807644}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Plasma; synthesized in the liver.
CC   -!- PTM: The vitamin K-dependent, enzymatic carboxylation of some glutamate
CC       residues allows the modified protein to bind calcium.
CC   -!- PTM: N- and O-glycosylated. {ECO:0000250}.
CC   -!- PTM: Proteolytically cleaved and activated by cathepsin CTSG (By
CC       similarity). The activation peptide is cleaved by factor IXa (in the
CC       intrinsic pathway), or by factor VIIa (in the extrinsic pathway) (By
CC       similarity). {ECO:0000250|UniProtKB:P00742,
CC       ECO:0000250|UniProtKB:P00743}.
CC   -!- PTM: The iron and 2-oxoglutarate dependent 3-hydroxylation of aspartate
CC       and asparagine is (R) stereospecific within EGF domains. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the peptidase S1 family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00274}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X79807; CAA56202.1; -; mRNA.
DR   EMBL; BC088151; AAH88151.1; -; mRNA.
DR   PIR; S49075; EXRT.
DR   RefSeq; NP_058839.1; NM_017143.2.
DR   AlphaFoldDB; Q63207; -.
DR   SMR; Q63207; -.
DR   STRING; 10116.ENSRNOP00000026677; -.
DR   BindingDB; Q63207; -.
DR   ChEMBL; CHEMBL3755; -.
DR   MEROPS; S01.216; -.
DR   GlyCosmos; Q63207; 2 sites, No reported glycans.
DR   GlyGen; Q63207; 2 sites.
DR   iPTMnet; Q63207; -.
DR   PhosphoSitePlus; Q63207; -.
DR   PaxDb; 10116-ENSRNOP00000026677; -.
DR   GeneID; 29243; -.
DR   KEGG; rno:29243; -.
DR   UCSC; RGD:61850; rat.
DR   AGR; RGD:61850; -.
DR   CTD; 2159; -.
DR   RGD; 61850; F10.
DR   eggNOG; ENOG502QS4N; Eukaryota.
DR   HOGENOM; CLU_006842_19_5_1; -.
DR   InParanoid; Q63207; -.
DR   OrthoDB; 4629979at2759; -.
DR   PhylomeDB; Q63207; -.
DR   TreeFam; TF327329; -.
DR   Reactome; R-RNO-140834; Extrinsic Pathway of Fibrin Clot Formation.
DR   Reactome; R-RNO-140837; Intrinsic Pathway of Fibrin Clot Formation.
DR   Reactome; R-RNO-140875; Common Pathway of Fibrin Clot Formation.
DR   Reactome; R-RNO-159740; Gamma-carboxylation of protein precursors.
DR   Reactome; R-RNO-159763; Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus.
DR   Reactome; R-RNO-159782; Removal of aminoterminal propeptides from gamma-carboxylated proteins.
DR   PRO; PR:Q63207; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005543; F:phospholipid binding; ISO:RGD.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; ISO:RGD.
DR   GO; GO:0007596; P:blood coagulation; IEA:UniProtKB-KW.
DR   GO; GO:0032008; P:positive regulation of TOR signaling; ISO:RGD.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   CDD; cd00054; EGF_CA; 1.
DR   CDD; cd00190; Tryp_SPc; 1.
DR   Gene3D; 4.10.740.10; Coagulation Factor IX; 1.
DR   Gene3D; 2.10.25.10; Laminin; 2.
DR   Gene3D; 2.40.10.10; Trypsin-like serine proteases; 2.
DR   InterPro; IPR017857; Coagulation_fac-like_Gla_dom.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR035972; GLA-like_dom_SF.
DR   InterPro; IPR000294; GLA_domain.
DR   InterPro; IPR012224; Pept_S1A_FX.
DR   InterPro; IPR050442; Peptidase_S1_coag_factors.
DR   InterPro; IPR009003; Peptidase_S1_PA.
DR   InterPro; IPR043504; Peptidase_S1_PA_chymotrypsin.
DR   InterPro; IPR001314; Peptidase_S1A.
DR   InterPro; IPR001254; Trypsin_dom.
DR   InterPro; IPR018114; TRYPSIN_HIS.
DR   InterPro; IPR033116; TRYPSIN_SER.
DR   PANTHER; PTHR24278; COAGULATION FACTOR; 1.
DR   PANTHER; PTHR24278:SF28; COAGULATION FACTOR X; 1.
DR   Pfam; PF00008; EGF; 1.
DR   Pfam; PF14670; FXa_inhibition; 1.
DR   Pfam; PF00594; Gla; 1.
DR   Pfam; PF00089; Trypsin; 1.
DR   PIRSF; PIRSF001143; Factor_X; 1.
DR   PRINTS; PR00722; CHYMOTRYPSIN.
DR   PRINTS; PR00010; EGFBLOOD.
DR   PRINTS; PR00001; GLABLOOD.
DR   SMART; SM00181; EGF; 2.
DR   SMART; SM00179; EGF_CA; 1.
DR   SMART; SM00069; GLA; 1.
DR   SMART; SM00020; Tryp_SPc; 1.
DR   SUPFAM; SSF57630; GLA-domain; 1.
DR   SUPFAM; SSF50494; Trypsin-like serine proteases; 1.
DR   PROSITE; PS00010; ASX_HYDROXYL; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS01186; EGF_2; 2.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS01187; EGF_CA; 1.
DR   PROSITE; PS00011; GLA_1; 1.
DR   PROSITE; PS50998; GLA_2; 1.
DR   PROSITE; PS50240; TRYPSIN_DOM; 1.
DR   PROSITE; PS00134; TRYPSIN_HIS; 1.
DR   PROSITE; PS00135; TRYPSIN_SER; 1.
PE   1: Evidence at protein level;
KW   Blood coagulation; Calcium; Cleavage on pair of basic residues;
KW   Disulfide bond; EGF-like domain; Gamma-carboxyglutamic acid; Glycoprotein;
KW   Hemostasis; Hydrolase; Hydroxylation; Protease; Reference proteome; Repeat;
KW   Secreted; Serine protease; Signal; Zymogen.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000255"
FT   PROPEP          21..40
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000027804"
FT   CHAIN           41..482
FT                   /note="Coagulation factor X"
FT                   /id="PRO_0000027805"
FT   CHAIN           41..180
FT                   /note="Factor X light chain"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000027806"
FT   CHAIN           184..482
FT                   /note="Factor X heavy chain"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000027807"
FT   PROPEP          184..231
FT                   /note="Activation peptide"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000027808"
FT   CHAIN           232..482
FT                   /note="Activated factor Xa heavy chain"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000027809"
FT   DOMAIN          41..85
FT                   /note="Gla"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00463"
FT   DOMAIN          86..122
FT                   /note="EGF-like 1; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          125..165
FT                   /note="EGF-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          232..465
FT                   /note="Peptidase S1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00274"
FT   ACT_SITE        274
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        320
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        417
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         46
FT                   /note="4-carboxyglutamate"
FT                   /evidence="ECO:0000250|UniProtKB:P00743,
FT                   ECO:0000255|PROSITE-ProRule:PRU00463"
FT   MOD_RES         47
FT                   /note="4-carboxyglutamate"
FT                   /evidence="ECO:0000250|UniProtKB:P00743,
FT                   ECO:0000255|PROSITE-ProRule:PRU00463"
FT   MOD_RES         54
FT                   /note="4-carboxyglutamate"
FT                   /evidence="ECO:0000250|UniProtKB:P00743,
FT                   ECO:0000255|PROSITE-ProRule:PRU00463"
FT   MOD_RES         56
FT                   /note="4-carboxyglutamate"
FT                   /evidence="ECO:0000250|UniProtKB:P00743,
FT                   ECO:0000255|PROSITE-ProRule:PRU00463"
FT   MOD_RES         59
FT                   /note="4-carboxyglutamate"
FT                   /evidence="ECO:0000250|UniProtKB:P00743,
FT                   ECO:0000255|PROSITE-ProRule:PRU00463"
FT   MOD_RES         60
FT                   /note="4-carboxyglutamate"
FT                   /evidence="ECO:0000250|UniProtKB:P00743,
FT                   ECO:0000255|PROSITE-ProRule:PRU00463"
FT   MOD_RES         65
FT                   /note="4-carboxyglutamate"
FT                   /evidence="ECO:0000250|UniProtKB:P00743,
FT                   ECO:0000255|PROSITE-ProRule:PRU00463"
FT   MOD_RES         66
FT                   /note="4-carboxyglutamate"
FT                   /evidence="ECO:0000250|UniProtKB:P00743,
FT                   ECO:0000255|PROSITE-ProRule:PRU00463"
FT   MOD_RES         69
FT                   /note="4-carboxyglutamate"
FT                   /evidence="ECO:0000250|UniProtKB:P00743,
FT                   ECO:0000255|PROSITE-ProRule:PRU00463"
FT   MOD_RES         72
FT                   /note="4-carboxyglutamate"
FT                   /evidence="ECO:0000250|UniProtKB:P00743,
FT                   ECO:0000255|PROSITE-ProRule:PRU00463"
FT   MOD_RES         75
FT                   /note="4-carboxyglutamate"
FT                   /evidence="ECO:0000250|UniProtKB:P00743,
FT                   ECO:0000255|PROSITE-ProRule:PRU00463"
FT   MOD_RES         79
FT                   /note="4-carboxyglutamate"
FT                   /evidence="ECO:0000250|UniProtKB:P00743,
FT                   ECO:0000255|PROSITE-ProRule:PRU00463"
FT   MOD_RES         103
FT                   /note="(3R)-3-hydroxyaspartate"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        187
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        218
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        57..62
FT                   /evidence="ECO:0000250"
FT   DISULFID        90..101
FT                   /evidence="ECO:0000250"
FT   DISULFID        95..110
FT                   /evidence="ECO:0000250"
FT   DISULFID        112..121
FT                   /evidence="ECO:0000250"
FT   DISULFID        129..140
FT                   /evidence="ECO:0000250"
FT   DISULFID        136..149
FT                   /evidence="ECO:0000250"
FT   DISULFID        151..164
FT                   /evidence="ECO:0000250"
FT   DISULFID        172..340
FT                   /note="Interchain (between light and heavy chains)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076,
FT                   ECO:0000255|PROSITE-ProRule:PRU00274, ECO:0000255|PROSITE-
FT                   ProRule:PRU00463"
FT   DISULFID        238..243
FT                   /evidence="ECO:0000250"
FT   DISULFID        259..275
FT                   /evidence="ECO:0000250"
FT   DISULFID        388..402
FT                   /evidence="ECO:0000250"
FT   DISULFID        413..441
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   482 AA;  54265 MW;  0284678E3954A698 CRC64;
     MESPVRLSLL YVVLASLLLP GRSVFINRER ANNVLQRIRR ANSFFEEIKK GNLERECVEE
     ICSFEEAREV FEDNEKTTEF WNKYEDGDQC ESSPCQNQGE CRDGLGSYTC TCTEGFEGKN
     CELFVRKLCS LDNGDCDQFC REEQNSVVCS CAKGYFLGND GKSCLSTAPF PCGKTNKGRA
     KRSVALNTSN SEPDPEDLMP DADILYPTES PSELLNLNKT EPEANSDDVI RIVGGQECKR
     GECPWQALLF SDEETDGFCG GTILNEFYIL TAAHCLHQAK RFKVRVGDLN TEQEDGGEMV
     HEVDMIIKHN KFQRDTYDFD IAMLRLKTPI TFRENVAPAC LPQKDWAEAT LMTQKTGIVS
     GFGRTHEKGR QSKVLKMMEV PYVDRNTCRL STSFSITQNM FCAGYDAKQE DACQGDSGGP
     HVTRFKDTYF VTGIVSWGEG CARKGKYGIY TKVTAFLKWI DRSMKARVGP TSETPRLTHP
     PY
//
